c-FMS (CSF1R, CSF-1R) is a receptor protein-tyrosine kinase of the platelet-derived growth factor receptor (PDGFR) family. The cell surface receptor for IL-34 and CSF1 is called c-FMS. Important functions of c-FMS include regulating haematopoiesis, cell survival, maturation of microglia and monocytes, and immune response regulation.
Osteoclasts and myelomonocytic-lineage cells, like monocytes and macrophages, express c-FMS specifically, and the activation of c-FMS signaling encourages the proliferation or differentiation of these cells. Additionally, it encourages the production of inflammatory mediators like interleukin 6 (IL6) and tumor necrosis factor-alpha (TNF-).
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V89056 | AZ683 | 953798-95-3 | AZ683 is a potent and selective 3-amino-4-phenylaminoquinoline CSF1R inhibitor. |
![]() |
V4238 | AZD7507 | 1041852-85-0 | AZD7507 is a novel, potent, selective and orally bioactive 3-amido-4-anilinoquinoline CSF-1R inhibitor with 32 nM cell activity and with antitumor activity. |
![]() |
V69288 | BPR1R024 mesylate | 2763365-40-6 | BPR1R024 mesylate is a selective, orally bioactive, colony-stimulating factor-1 receptor (CSF1R) inhibitor. |
![]() |
V69274 | c-Fms-IN-13 | 885704-58-5 | c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (antagonist) with IC50 of 17 nM. |
![]() |
V69272 | c-Fms-IN-14 | 1898210-99-5 | c-Fms-IN-14 (Example 76) is a c-Fms inhibitor (antagonist) with IC50 of 4 nM. |
![]() |
V88002 | c-Fms-IN-15 | c-Fms-IN-15 (compound 8g) is a potent inhibitor of FMS kinase with IC50 of 563 nM. | |
![]() |
V4438 | cFMS Receptor Inhibitor II | 959860-85-6 | cFMS Receptor Inhibitor II (BUN60856; BUN-60856) is a novel, cell-permeable and potent CSF1R (Colony stimulating factor 1 receptor) kinase inhibitor with an IC50 of 80 nM. |
![]() |
V69284 | cFMS Receptor Inhibitor IV | 959626-45-0 | cFMS receptor blocker/inhibitor IV (Compound 42) is a potent inhibitor of cFMS with IC50 of 0.017 μM. |
![]() |
V31740 | CSF1R-IN-1 | 2095849-04-8 | CSF1R-IN-1 is an inhibitor (blocker/antagonist) of CSF1R with IC50 of 0.5 nM. |
![]() |
V69287 | CSF1R-IN-15 | 2925744-43-8 | CSF1R-IN-15 (compound 23) is an inhibitor (blocker/antagonist) of c-Fms. |
![]() |
V79871 | CSF1R-IN-17 | CSF1R-IN-17 (compound 9) is a potent and specific CSF1R antagonist (inhibitor) with IC50 of 0.2 nM. | |
![]() |
V85452 | CSF1R-IN-18 | ||
![]() |
V85255 | CSF1R-IN-19 | 1819989-27-9 | |
![]() |
V88003 | CSF1R-IN-20 | 2935479-57-3 | CSF1R-IN-20 (compound 7a) is a CSF-1R inhibitor with IC50 of 467 nM. |
![]() |
V88000 | CSF1R-IN-21 | 2935479-62-0 | CSF1R-IN-21 (compound 7e) is a CSF-1R inhibitor with an IC50 value of 31 nM. |
![]() |
V87998 | CSF1R-IN-23 | 2935480-17-2 | CSF1R-IN-23 (Compound 7dri) is a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R) with an IC50 of 36.1 nM. |
![]() |
V87997 | CSF1R-IN-24 | 3024322-57-1 | CSF1R-IN-24 (Example 134) is an orally active CSF1R inhibitor. |
![]() |
V88001 | CSF1R-IN-25 | 2070864-23-0 | CSF1R-IN-25 (compound 36) is an orally available inhibitor of CSF1R. |
![]() |
V94235 | Edicotinib hydrochloride | 1559069-92-9 | Aditinib hydrochloride is a potent, selective, blood-brain penetrant, and orally available CSF-1R inhibitor with IC50 of 3.2 nM. |
![]() |
V69277 | Eflapegrastim | 1384099-30-2 | Eflapegrastim is a humanized IgG4 monoclonal antibody (mAb) and a granulocyte colony-stimulating factor (G-CSF). |